Torii Pharmaceutical Co., Ltd. (TYO:4551)

Torii Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,767	3,319	5,004	9,203	4,012	3,717
Short-Term Investments	36,974	39,979	38,999	49,706	61,560	66,387
Cash & Short-Term Investments	40,741	43,298	44,003	58,909	65,572	70,104
Cash Growth	0.15%	-1.60%	-25.30%	-10.16%	-6.46%	-8.62%
Accounts Receivable	26,906	31,068	28,502	22,865	22,010	18,955
Receivables	26,906	31,068	28,502	22,865	22,010	18,955
Inventory	15,820	14,217	10,742	8,969	8,763	7,151
Prepaid Expenses	-	1,225	663	307	152	145
Other Current Assets	7,220	4,832	4,238	553	795	387
Total Current Assets	90,687	94,640	88,148	91,603	97,292	96,742
Property, Plant & Equipment	2,570	2,451	2,095	2,282	2,078	1,777
Long-Term Investments	43,134	42,444	41,895	38,636	30,286	26,477
Other Intangible Assets	298	321	429	517	512	442
Long-Term Deferred Tax Assets	-	805	863	650	641	587
Other Long-Term Assets	-	3	2	1	1	1
Total Assets	136,689	140,664	133,432	133,689	130,810	126,026
Accounts Payable	10,105	10,448	6,981	6,584	5,793	5,143
Accrued Expenses	863	967	931	753	812	689
Current Portion of Leases	-	148	222	283	211	85
Current Income Taxes Payable	519	5,979	3,708	4,920	4,863	3,127
Other Current Liabilities	3,064	611	662	681	693	417
Total Current Liabilities	14,551	18,153	12,504	13,221	12,372	9,461
Long-Term Leases	-	281	22	241	275	209
Other Long-Term Liabilities	561	303	295	296	312	318
Total Liabilities	15,486	19,131	13,299	14,465	13,796	10,936
Common Stock	5,190	5,190	5,190	5,190	5,190	5,190
Additional Paid-In Capital	6,473	6,473	6,460	6,453	6,445	6,437
Retained Earnings	110,518	110,813	109,425	108,846	106,250	104,224
Treasury Stock	-1,358	-1,358	-1,369	-1,381	-1,393	-1,407
Comprehensive Income & Other	380	415	427	116	522	646
Shareholders' Equity	121,203	121,533	120,133	119,224	117,014	115,090
Total Liabilities & Equity	136,689	140,664	133,432	133,689	130,810	126,026
Total Debt	-	429	244	524	486	294
Net Cash (Debt)	40,741	42,869	43,759	58,385	65,086	69,810
Net Cash Growth	0.15%	-2.03%	-25.05%	-10.30%	-6.77%	-8.55%
Net Cash Per Share	1449.31	1525.10	1557.09	2078.05	2317.05	2486.00
Filing Date Shares Outstanding	28.11	28.11	28.11	28.1	28.09	28.08
Total Common Shares Outstanding	28.11	28.11	28.11	28.1	28.09	28.08
Working Capital	76,136	76,487	75,644	78,382	84,920	87,281
Book Value Per Share	4311.56	4323.54	4274.28	4243.45	4165.24	4098.35
Tangible Book Value	120,905	121,212	119,704	118,707	116,502	114,648
Tangible Book Value Per Share	4300.96	4312.12	4259.02	4225.05	4147.01	4082.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.